Rockefeller Capital Management L.P. Takes Position in Merit Medical Systems, Inc. (MMSI)

Rockefeller Capital Management L.P. acquired a new stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 778,769 shares of the medical instruments supplier’s stock, valued at approximately $35,317,000. Rockefeller Capital Management L.P. owned about 1.55% of Merit Medical Systems as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in MMSI. Eagle Asset Management Inc. raised its position in shares of Merit Medical Systems by 209.5% in the 4th quarter. Eagle Asset Management Inc. now owns 1,874,146 shares of the medical instruments supplier’s stock valued at $81,018,000 after purchasing an additional 1,268,635 shares during the last quarter. Carillon Tower Advisers Inc. purchased a new position in shares of Merit Medical Systems in the 4th quarter valued at approximately $13,788,000. Perceptive Advisors LLC raised its position in shares of Merit Medical Systems by 774.0% in the 4th quarter. Perceptive Advisors LLC now owns 874,013 shares of the medical instruments supplier’s stock valued at $37,757,000 after purchasing an additional 774,013 shares during the last quarter. OppenheimerFunds Inc. raised its position in shares of Merit Medical Systems by 2,548.7% in the 4th quarter. OppenheimerFunds Inc. now owns 313,866 shares of the medical instruments supplier’s stock valued at $13,559,000 after purchasing an additional 302,016 shares during the last quarter. Finally, Allianz Asset Management GmbH raised its position in shares of Merit Medical Systems by 305.6% in the 4th quarter. Allianz Asset Management GmbH now owns 333,409 shares of the medical instruments supplier’s stock valued at $14,403,000 after purchasing an additional 251,204 shares during the last quarter. 95.97% of the stock is owned by hedge funds and other institutional investors.

Shares of Merit Medical Systems opened at $53.70 on Friday, Marketbeat reports. Merit Medical Systems, Inc. has a twelve month low of $32.85 and a twelve month high of $53.75. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.42 and a current ratio of 2.76. The company has a market capitalization of $2.71 billion, a P/E ratio of 40.68, a price-to-earnings-growth ratio of 2.53 and a beta of 1.33.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings results on Wednesday, April 25th. The medical instruments supplier reported $0.31 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.29 by $0.02. Merit Medical Systems had a net margin of 2.37% and a return on equity of 10.01%. The company had revenue of $203.04 million for the quarter, compared to the consensus estimate of $192.60 million. During the same quarter in the prior year, the company earned $0.28 EPS. Merit Medical Systems’s quarterly revenue was up 18.7% on a year-over-year basis. analysts forecast that Merit Medical Systems, Inc. will post 1.64 earnings per share for the current year.

MMSI has been the subject of several research analyst reports. Zacks Investment Research lowered shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Thursday, January 25th. BidaskClub lowered shares of Merit Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, January 26th. Barrington Research raised shares of Merit Medical Systems from a “market perform” rating to an “outperform” rating and set a $50.00 price objective for the company in a research report on Thursday, March 1st. Canaccord Genuity increased their price objective on shares of Merit Medical Systems from $50.00 to $57.00 and gave the company a “buy” rating in a research report on Thursday, March 1st. Finally, SunTrust Banks increased their price objective on shares of Merit Medical Systems from $1.64 to $55.00 and gave the company a “buy” rating in a research report on Wednesday, March 7th. One investment analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $50.42.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets various disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides various peripheral intervention products, including access, angiography, intervention, and drainage and biopsy products to alleviate patients suffering from peripheral vascular and non-vascular diseases; and cardiac intervention products to aid in the treatment of various cardiac conditions specific to interventional cardiology and electrophysiology, including cardiac rhythm management and lead management.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI).

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply